LESLIE ZECKSER: Open Payments
NPI 1235549940 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,545 in 147 payments from 23 companies in 2025. Trend: 2023 $3,074 · 2024 $3,696 · 2025 $3,545
Food & beverage: $3,468Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $556 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $528 |
| Madrigal Pharmaceuticals | 6 | $305 |
| Gilead Sciences, Inc. | 11 | $227 |
| Ardelyx, Inc. | 9 | $224 |
| Janssen Scientific Affairs, LLC | 2 | $212 |
| QOL Medical, LLC | 6 | $168 |
| Janssen Biotech, Inc. | 6 | $165 |
| GENZYME CORPORATION | 5 | $162 |
| Intercept Pharmaceuticals, Inc. | 8 | $145 |
Products named: ENTYVIO, RINVOQ, TREMFYA, REZDIFFRA, DUPIXENT, IBSRELA, Sucraid, OCALIVA.
Industry payments across AZ — which companies pay providers there.
